Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative to cancel up to 50% of his restricted common stock holdings in exchange for a newly designated class of preferred equity. This move is intended to optimize the company's common equity base, enhance strategic flexibility, and align executive equity participation with corporate development goals.
The company, focused on AI-driven healthcare solutions for emerging markets, believes the transaction will contribute to a more disciplined equity framework and support long-term strategic initiatives, including future financing opportunities, strategic partnerships, and operational development. Management also expects the restructuring to strengthen alignment between executive leadership and corporate performance objectives while reinforcing commitment to shareholder-oriented growth.
Kevin Roldan Levy stated, 'This initiative reflects my long-term commitment to the Company’s strategic development and disciplined capital structure management. As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation.'
The company is finalizing the structure and designation of the new preferred equity and expects to provide additional updates upon completion. Catalyst Crew continues its transition into AI-enabled healthcare, focusing on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets.
For more information, visit https://catalystcrewai.com or review the company's SEC filings at www.sec.gov.
